NextCure, Inc. (NXTC) Social Stream
NextCure Inc (NXTC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NextCure Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-14 | 6 | $21 | $10 | $15 | $4.86 | 208.64% |
| 2021-11-15 | 6 | $21 | $11 | $15.5 | $4.86 | 218.93% |
| 2021-12-03 | 6 | $21 | $7 | $14.5 | $4.86 | 198.35% |
| 2021-12-13 | 5 | $21 | $7 | $15.2 | $4.86 | 212.76% |
| 2022-01-11 | 6 | $21 | $7 | $15.5 | $4.86 | 218.93% |
| 2022-02-04 | 6 | $21 | $7 | $14.5 | $4.86 | 198.35% |
| 2022-03-04 | 6 | $21 | $7 | $14.714 | $4.86 | 202.76% |
| 2022-03-13 | 7 | $21 | $7 | $14.714 | $4.86 | 202.76% |
The Trend in the Analyst Price Target
NXTC's average price target has moved down $8.62 over the prior 14 months.
Over the past 49 weeks, NXTC's average upside potential has been 147.18%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-07-17 | 5 | 30 | 10 | 18.290 | 7.23 | 152.97% |
| 2021-09-18 | 5 | 30 | 10 | 17.570 | 7.00 | 151% |
| 2021-09-19 | 5 | 30 | 10 | 17.570 | 7.00 | 151% |
| 2022-02-04 | 7 | 21 | 7 | 14.500 | 5.34 | 171.54% |
| 2022-03-04 | 6 | 21 | 7 | 14.714 | 4.76 | 209.12% |
NXTC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.86 | 4 | 1 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
NXTC's average broker recommendation rating improved by 0.47 over the prior 120 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NXTC as an investment opportunity.
- NXTC has a higher upside potential (average analyst target price relative to current price) than 794.27% of all US stocks.
- In terms of how NextCure Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -684.22% of that group.
- In the context of all US stocks, NextCure Inc's average analyst price target is greater than 143.92% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, NextCure Inc's number of analysts covering the stock is higher than 704.49% of them.
Stocks similar to NextCure Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NWBO, NUVL, and NRXP.
Is NXTC a Buy, Hold or Sell? See the POWR Ratings now!